Last reviewed · How we verify

NCT05650437

Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women

Completed NA Last updated 12 January 2024
What this trial tests

NA trial testing Ultraviolet Radiation in Postmenopausal Osteoporosis in 70 participants. Completed in 15 December 2023.

Timeline
30 December 2022
Primary endpoint
13 September 2023
15 December 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment70
Start date30 December 2022
Primary completion13 September 2023
Estimated completion15 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 50 to 65, female only, with Postmenopausal Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

70 postmenopausal women, aged 50 to 60, who are vitamin D deficient and diagnosed with osteoporosis or osteopenia with T score of DEXA of lumbar spine (L1 to L4) was less than or equal -1 and their body mass index between 25 and 30 kg/m2. They will be divided into two groups by randomization. 35 postmenopausal women in Group (A) will undergo three weekly sessions of UV therapy in addition to routine aerobic activity and vitamin D supplements (800 IU) daily for three months. For three months, group (B), which consists of 35 postmenopausal women, will undergo daily aerobic exercise and vitamin D supplementation (800 IU) only. The amount of serum 25-hydroxyvitamin D was measured using ELISA kits, bone mineral density of lumber spine was measured by dual energy X-ray absorptiometry (DEXA), and the torque of knee flexors and extensors was evaluated using the Biodex System 3 isokinetic dynamometer,

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of ultraviolet radiation on bone density and muscle strength in postmenopausal women: a randomized controlled study.
    Kamal WM, Maged AM, Salah N, El-Goly NA, et al · · 2025 · cited 1× · PMID 40534210 · DOI 10.5468/ogs.25077

Verify or expand the search:

Other recruiting trials for Postmenopausal Osteoporosis

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05650437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing